Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 7;20(4):324–335. doi: 10.1093/ijnp/pyw106

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2016. Published by Oxford University Press on behalf of CINP.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 5. — Behavioral alterations by the D1 antagonist in the nonhuman primate. (a) A graph showing the number of goal-directed actions per observation day in the drug-treated subject under the baseline (BASE), saline (SAL), and SCH23390 (SCH) conditions. *P<.001, **P=.002. (b) A histogram illustrating the changes in number of goal-directed actions on each observation day across the BASE, SAL, and SCH conditions. (c-d) Graphs similar to a and b, but showing agonistic display. *P=.001, **P=.005. (e-g) Graphs showing that neither scanning (e), stereotypy (f), nor locomotion (g) was altered by SCH administration.